Abstract
Summary1,25-Dihydroxycholecaliferol (1,25-DHCC) is a metabolite of vitamin D produced in the kidney from the major circulating biologically active form of the vitamin, 25-hydroxycholecalciferol (25-HCC) and has been demonstrated to be the derivative of cholecalciferol (CC) primarily responsible for the initiation of calcium transport from the gut contents. Because previous studies have shown that both CC and 25-HCC act acutely to enhance phosphate, sodium and calcium reabsorption in the kidney, the effect of 1,25-DHCC was evaluated in clearance studies performed in mildly expanded thyroparathyroidectomized dogs. In a dose of 25 U (0.625 μg), 1,25-DHCC induced an invariable fall in both fractional and absolute phosphate excretion (mean declines of 40 and 36%, respectively, p < .05 and < .01). Fractional sodium and calcium excretion also deccreased by mean values of 26 and 36%, respectively (p < .02). Renal hemodynamic changes and alterations in serum ultrafilterable calcium and phosphate concentrations did...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
